Checkmate Pharmaceuticals, Inc.
CMPIDelisted May 31, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001651431
Checkmate Pharmaceuticals, Inc. was delisted on May 31, 2022; its insiders filed their last Form 4 on May 31, 2022; 26 institutions reported holding it in 13F filings for Q1 2022, worth $54.8M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Checkmate Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 26 | 0 | −26 |
| Shares | 17.2M | 0 | −17.2M (−100.0%) |
| Value | $54.8M | $0 | −$54.8M (−100.0%) |
New holders (0)
Institutions that held Checkmate Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
None.
Sold out (26)
Institutions that held Checkmate Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| venBio Partners LLC | 3,673,374 | $11.7M |
| Sofinnova Investments, Inc. | 3,606,707 | $11.5M |
| Novo Holdings A/S | 2,161,990 | $6.90M |
| Medicxi Ventures Management (Jersey) Ltd | 1,501,716 | $4.79M |
| Omega Fund Management, LLC | 1,335,050 | $4.26M |
| Decheng Capital Management III (Cayman), LLC | 1,333,254 | $4.25M |
| Clough Capital Partners L P | 1,137,764 | $3.63M |
| FMR LLC | 966,226 | $3.08M |
| Vanguard Group Inc | 556,423 | $1.77M |
| Sectoral Asset Management Inc | 541,765 | $1.73M |
| Bridgeway Capital Management, LLC | 106,500 | $340.0K |
| RBF Capital, LLC | 68,034 | $219.0K |
| BlackRock Inc. | 51,334 | $164.0K |
| Geode Capital Management, LLC | 41,466 | $132.0K |
| Federated Hermes, Inc. | 30,636 | $98.0K |
| Cambridge Trust Co | 24,609 | $79.0K |
| Barclays PLC | 14,553 | $46.0K |
| State Street Corp | 11,424 | $36.0K |
| Morgan Stanley | 3,005 | $10.0K |
| US Bancorp | 2,000 | $6.00K |
| Tower Research Capital LLC (TRC) | 1,940 | $6.00K |
| UBS Group AG | 183 | $1.00K |
| Johnson Midwest Financial, LLC | 200 | $1.00K |
| JPMorgan Chase & Co | 49 | $0 |
| Bank of America Corp | 1 | $0 |
| Wells Fargo & Company | 33 | $0 |